Mustang Bio MBIO
$ 0.21
-0.87%
Quarterly report 2024-Q3
added 11-08-2024
Mustang Bio Balance Sheet 2011-2024 | MBIO
Annual Balance Sheet Mustang Bio
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-3.74 M | -71.7 M | -108 M | -95.6 M | -48 M | -16.5 M | -35 M | -27.2 M | 3.57 M | - | - | - | - |
Long Term Debt |
1.98 M | 3.33 M | 1.68 M | - | 12.2 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
520 K | 612 K | 348 K | 278 K | 257 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 1.95 M | 14 M | 741 K | 50 K | - | - | - | - | - | - |
Total Current Liabilities |
15.4 M | 15.1 M | 10.8 M | 9.52 M | 7.77 M | 5.62 M | 3.61 M | 3.22 M | - | - | - | - | - |
Total Liabilities |
17.6 M | 46.1 M | 12.8 M | 11.5 M | 21.8 M | 6.36 M | 3.66 M | 3.22 M | 4.13 M | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-381 M | -329 M | -252 M | -185 M | -125 M | -79.1 M | -48.4 M | -17.1 M | -4.47 M | - | - | - | - |
Total Assets |
17.7 M | 92.4 M | 125 M | 110 M | 73.4 M | 42.8 M | 63.5 M | 27.5 M | - | - | - | - | - |
Cash and Cash Equivalents |
6.23 M | 75.7 M | 110 M | 97.8 M | 61.4 M | 17 M | 35.5 M | 27.5 M | - | - | - | - | - |
Book Value |
123 K | 46.3 M | 112 M | 98.4 M | 51.7 M | 36.4 M | 59.8 M | 24.3 M | -4.13 M | - | - | - | - |
Total Shareholders Equity |
123 K | 46.3 M | 112 M | 98.4 M | 51.7 M | 36.4 M | 59.8 M | 24.3 M | -4.13 M | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Mustang Bio
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
541 K | 656 K | 1.83 M | 2.12 M | 2.24 M | 3.28 M | 3.33 M | 3.39 M | 1.5 M | 1.59 M | 1.68 M | 1.76 M | 1.82 M | 1.88 M | 1.95 M | 1.95 M | 1.95 M | 1.95 M | 1.84 M | 1.84 M | 1.84 M | 1.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
15.8 M | 16.8 M | 19.5 M | 16.6 M | 15.4 M | 43.8 M | 46.1 M | 44.5 M | 39.9 M | 39.6 M | 12.8 M | 12.5 M | 8.18 M | 8.46 M | 11.5 M | 11.5 M | 11.5 M | 11.5 M | 21.8 M | 21.8 M | 21.8 M | 22 M | 6.36 M | 6.36 M | 6.36 M | 6.36 M | 3.66 M | 3.66 M | 3.66 M | 3.66 M | 3.22 M | 3.22 M | 3.22 M | 3.22 M | 4.13 M | 4.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-396 M | -394 M | -386 M | -372 M | -362 M | -346 M | -329 M | -310 M | -291 M | -272 M | -252 M | -232 M | -215 M | -200 M | -185 M | -185 M | -185 M | -185 M | -125 M | -125 M | -125 M | -88.7 M | -79.1 M | -79.1 M | -79.1 M | -79.1 M | -48.4 M | -48.4 M | -48.4 M | -48.4 M | -17.1 M | -17.1 M | -17.1 M | -17.1 M | -4.47 M | -4.47 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
7.19 M | 8.52 M | 14.6 M | 20.6 M | 29.1 M | 73.6 M | 92.4 M | 109 M | 122 M | 137 M | 125 M | 135 M | 143 M | 142 M | 110 M | 110 M | 110 M | 110 M | 73.4 M | 73.4 M | 73.4 M | 50.5 M | 42.8 M | 42.8 M | 42.8 M | 42.8 M | 63.5 M | 63.5 M | 63.5 M | 63.5 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
3.52 M | 4.27 M | 1.34 M | 9.56 M | 15.4 M | 58.1 M | 75.7 M | 91.4 M | 107 M | 122 M | 110 M | 121 M | 130 M | 129 M | 97.8 M | 97.8 M | 97.8 M | 97.8 M | 61.4 M | 61.4 M | 61.4 M | 36.1 M | 16.5 M | 16.5 M | 17 M | 17 M | 35.5 M | 33.2 M | 53.8 M | 75 M | 27.5 M | 11.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
-8.66 M | -8.33 M | -4.94 M | 4.01 M | 13.7 M | 29.8 M | 46.3 M | 64.3 M | 82 M | 97.3 M | 112 M | 122 M | 135 M | 133 M | 98.4 M | 98.4 M | 98.4 M | 98.4 M | 51.7 M | 51.7 M | 51.7 M | 28.5 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 59.8 M | 59.8 M | 59.8 M | 59.8 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | -4.13 M | -4.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-8.66 M | -8.33 M | -4.94 M | 4.01 M | 13.7 M | 29.8 M | 46.3 M | 64.3 M | 82 M | 97.3 M | 112 M | 122 M | 135 M | 133 M | 98.4 M | 98.4 M | 98.4 M | 98.4 M | 51.7 M | 51.7 M | 51.7 M | 28.5 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 59.8 M | 59.8 M | 59.8 M | 59.8 M | 24.3 M | 24.3 M | 24.3 M | 24.3 M | -4.13 M | -4.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency